3010
R. J. Schmidt et al. / Tetrahedron Letters 49 (2008) 3009–3010
Table 1
A general two step, one-pot Biginelli reaction to generate 5-cyano-4-substituted dihydropyrimidinones
R
O
R
NC
Me
2.3 eq PPE
0.3 eq PPE
O
O
O
NH
H2N
NH
RCHO
+
+
NH2 H2N
NH2
N
H
O
Me
N
H
O
Entry
R
Yielda,b,c (%)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
3-NO2-Phenyl
3-Cl-Phenyl
3-CF3-Phenyl
2-Thienyl
5-NO2-2-Thienyl
4-Br-2-Thienyl
4-Ph-2-Thienyl
3-Thienyl
5-meta-Cl-Phenyl-2-furanyl
5-meta-Cl-Phenyl-2-EtO2C-2-furanyl
6-Me-2-Pyridyl
t-Butyl
n-Butyl
94
78
70
72
91
68
91
51
38
27
70
34
97
77
Isopropyl
15
16
a
Methyl-benzyl ether
1-Methyl-1-pentyl
45
4
See Ref. 14 for general procedure.
b
c
Isolated yields after purification by SiO2 gel chromatography.
Characterized by 1H NMR, elemental analysis, and LC/MS.
5. Atwal, K. S.; O’Rielly, B. C.; Gougoutas, J.; Malley, M. Heterocycles
1987, 26, 1189–1192.
6. Atwal, K. S.; Rovnyak, G. C.; O’Reilly, B.; Schwartz, J. J. Org.
Chem. 1989, 54, 5898–5907.
7. Kappe, C. O. Tetrahedron 1993, 49, 6937–6963.
8. Hu, E. H.; Sidler, D. R.; Dolling, U. H. J. Org. Chem. 1998, 63, 3454–
3457.
A variety of substituted aromatic, aliphatic, and hetero-
aromatic aldehydes, with either electron-donating or elec-
tron-withdrawing groups, provided favorable results in
this reaction. For example, 5-cyano-dihydropyrimidinones
generated from 3-nitro and 4-phenyl-2-thienyl benzalde-
hyde afforded the corresponding products in greater than
90% yield. Aliphatic aldehydes were equally amenable to
these conditions with n-butyraldehyde providing the 5-
cyano-dihydropyrimidinone in 97% yield. Quaternary sub-
stitution at the 4-position of the DHPM could also be
achieved with ketones using this methodology, albeit in
significantly lower yields (compounds 15 and 16).
In summary, a new method for the preparation of
substituted 5-cyano-DHPMs was discovered that utilizes
a multicomponent coupling reaction promoted by PPE,
followed by a rapid and high yielding PPE-mediated dehy-
dration to afford the corresponding carbonitrile. The use of
PPE was well tolerated with a range of aldehydes and
ketones. In addition, this methodology is cost effective
and amenable to large-scale synthesis.
9. Yadav, J. S.; Subba, B. V.; Reddy, S.; Srinivas, R.; Venugopal, C.;
Ramalingam, T. Synthesis 2001, 9, 1341–1345.
10. Das, B.; Srinivas, K. Synthesis 2004, 13, 2091–2093.
11. Kappe, C. O.; Falsone, F. S. Synlett 1998, 7, 718–720.
12. Kappe, C. O.; Falsone, F. S. ARKIVOC 2001, ii, 122–134.
13. Kappe, C. O.; Roschger, P. J. Heterocycl. Chem. 1989, 26,
55–64.
14. Dixon, L. A. In Encyclopedia of Reagents for Organic Synthesis;
Paquette, L., Ed.; Wiley: Chichester, 1995; Vol. 6, pp 4166–4169.
Caution: PPE is stable refrigerated but decomposition occurs above
150 °C.
15. Typical procedure for the synthesis of 5-cyano-dihydropyrimidinones: A
mixture of 3-nitrobenzaldehyde (5.0 g, 33 mmol, 1.0 equiv), acetoac-
etamide (3.3 g, 33 mmol, 1.0 equiv), urea (3.0 g, 50 mmol, 1.5 equiv),
and polyphosphate ester (4.2 g, 10 mmol, 0.3 equiv) in THF (35 mL)
was heated in a sealed tube for 45 min at 75 °C. This mixture was
cooled to room temperature, additional polyphosphate ester (33 g,
76 mmol, 2.3 equiv) was added, and the heating was resumed at 85 °C
for 3 h. The reaction mixture was cooled to room temperature and
poured onto ice (800 g). The resulting precipitate was collected by
vacuum filtration and the solid washed with water followed by a small
amount of methanol and diethyl ether. The solid was then dried under
vacuum to yield 6-methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydro-
pyrimidine-5-carbonitrile as a light yellow solid (8.0 g; 94%) that was
used without further purification: 1H NMR (DMSO-d6, 400 MHz) d
9.70 (s, 1H), 8.21–8.23 (m, 1H), 8.16–8.17 (m, 1H), 7.98–8.00 (m, 1H),
7.80–7.81 (m, 1H), 7.74 (t, 1H, J = 7.9 Hz), 5.38 (s, 1H), 2.02 (s, 3H).
Anal. Calcd for C12H10N4O3: C, 55.81; H, 3.90; N, 21.69. Found: C,
55.79; H, 3.92; N, 21.52. MS: (MÀH)À 257.
References and notes
1. Kappe, C. O. Eur. J. Med. Chem. 2000, 35, 1043–1052.
2. Bose, S.; Kumar, R.; Fatima, L. Synlett 2004, 2, 279–282.
3. Kimball, D., Lombardo, L., Rawlins, D., Xiao, H., Roussell, D. A
Method of Treating Proliferative Diseases Using Eg5 Inhibitors. PCT
Patent Application 2002/165240, 2002; Lombardo, L., Wu, L. Cyano-
Substituted Dihydropyrimidine Compounds and Their Use to Treat
Disease. U.S. Patents 6,809,102, 2004 and 6,900,214, 2005.
4. Atwal, K. S.; O’Reilly, B. C. Heterocycles 1987, 26, 1185–1188.